Yosemite
San Francisco, Californiayosemite.co
Overview
Yosemite is an investment firm based in San Francisco that aims to make cancer non-lethal within our lifetime . The firm partners with researchers and entrepreneurs to fund advancements across the oncology ecosystem and accelerate the development of new therapies . Yosemite deploys capital from early non-profit grantees through late-stage companies .
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Chai Discovery | Jul 2026 | Series C | Co-investor |
| HistoSonics | Jun 2026 | VC Round | Co-investor |
| Turquoise Health | Mar 2026 | Series C | Co-investor |
| Ten63 Therapeutics | Feb 2026 | Strategic | Co-investor |
| Ten63 Therapeutics | Feb 2026 | Strategic | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
